Europska Unija - hrvatski - EMA (European Medicines Agency)

novartis europharm limited - вилдаглиптин, metformin hidroklorid - dijabetes mellitus, tip 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - icandra is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 i 5. 1 za dostupne podatke o različitim kombinacijama).

Europska Unija - hrvatski - EMA (European Medicines Agency)

merck sharp & dohme b.v. - ertugliflozin l-pyroglutamic acid, metformin hydrochloride - dijabetes mellitus, tip 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - segluromet is indicated in adults aged 18 years and older with type 2 diabetes mellitus as an adjunct to diet and exercise to improve glycaemic control:in patients not adequately controlled on their maximally tolerated dose of metformin alonein patients on their maximally tolerated doses of metformin in addition to other medicinal products for the treatment of diabetesin patients already being treated with the combination of ertugliflozin and metformin as separate tablets.

Europska Unija - hrvatski - EMA (European Medicines Agency)

novartis europharm limited - вилдаглиптин, metformin hidroklorid - dijabetes mellitus, tip 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - eucreas is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control.

Europska Unija - hrvatski - EMA (European Medicines Agency)

eli lilly nederland b.v. - dulaglutide - dijabetes mellitus, tip 2 - drugs used in diabetes, blood glucose lowering drugs, excl. insulins - trulicity is indicated for the treatment of patients 10 years and above with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exerciseas monotherapy when metformin is considered inappropriate due to intolerance or contraindicationsin addition to other medicinal products for the treatment of diabetes. prema rezultatima istraživanja u vezi kombinacije, utjecaj na glikemijski kontrolu i kardiovaskularnih događaja, a u ispitivanih skupina, vidi 4. 4, 4. 5 i 5.

Europska Unija - hrvatski - EMA (European Medicines Agency)

merck sharp & dohme b.v. - ertugliflozin l-pyroglutamic kiselina - dijabetes mellitus, tip 2 - drugs used in diabetes, sodium-glucose co-transporter 2 (sglt2) inhibitors - steglatro prikazan u odraslih osoba u dobi od 18 godina i stariji sa dijabetesom tipa 2 kao dodatak prehrani i fizičke vježbe za poboljšanje glikemijski kontrole:kao monoterapija kod bolesnika za koje primjena метформина se smatra da je neprimjereno zbog netolerancije ili kontraindikacija. osim drugih lijekova za liječenje šećerne bolesti.

Europska Unija - hrvatski - EMA (European Medicines Agency)

merck sharp & dohme b.v. - ertugliflozin l-pyroglutamic kiselina monohidrat fosfata ситаглиптин - dijabetes mellitus, tip 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - steglujan prikazan u odraslih osoba u dobi od 18 godina i stariji sa dijabetesom tipa 2 kao dodatak prehrani i fizičke vježbe za poboljšanje glikemijski kontrole:kada метформина i/ili sulfonilureje (su) i jedan od однокомпонентных od steglujan ne pružaju adekvatnu glikemijski kontrole. kod bolesnika se liječi s kombinacijom ertugliflozin i ситаглиптина kao zasebne tableta.

Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

abbott laboratories d.o.o., zagreb - glukometar za brzo određivanje koncentracije glukoze u perifernoj krvi i kontrolna otopina

Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

salvus d.o.o., donja stubica - in vitro dijagnostika, test trake za analizu urina

Hrvatska - hrvatski - HALMED (Agencija za lijekove i medicinske proizvode)

oktal pharma d.o.o., zagreb - sustav za kontinuirano praćenje razine glukoze u krvi u međustaničnoj tekućini potkožnog tkiva

Hrvatska - hrvatski - Ministarstvo poljoprivrede, Uprava za Veterinarstvo i sigurnost hrane

zoetis netherlands holdings b.v. podružnica zagreb za promidžbu, petra hektorovića 2, zagreb, hrvatska - vrećica a: glicin, limunska kiselina, kalijev citrat, kalijev dihidrogenfosfat i natrijev klorid; vrećica b: glukoza monohidrat - prašak za peroralnu otopinu - teladi, svinja, janadi i konja